Objectives: Japanese encephalitis (JE) is one of the major mosquito-borne infectious diseases in the Western Pacific region, accounting for 20%-30% of mortality cases. The JE virus (JEV) seroprevalence fluctuations indicate that continuous research is important for prevention and control activities. By mapping JEV seroprevalence by age stratification, the population profile for immunity and susceptibility can be identified to aid in vaccination program planning. Thus, this study aimed to determine the trend of age-specific JEV seroprevalence.
Methods: We conducted a systematic review of all studies conducted on JEV seroprevalence between 2010 and 2019. The two search engines used were PubMed and Web of Science. Eligible criteria were set, and articles were screened according to the Preferred Reporting Items for Systematic Reviews and Meta- Analyses guidelines. Three investigators cross-checked all articles assigned. Data were extracted into an Excel sheet, and results were tabulated in tables and graphs accordingly.
Results: Four studies from four countries (Taiwan, Sri Lanka, South Korea, and India) met the eligibility criteria. The papers showed an increasing trend of JEV seropositivity in all countries as their populations reach older age cohorts. Nonetheless, there were slight downtrend notches seen among young adults in Taiwan and India before increasing after reaching more mature ages. South Korea has the highest seroprevalence rate (97.8%-98.3%) among the compared countries. This is most likely because it was the earliest to introduce the JEV vaccine in 1967, which was later made mandatory in the early 1980s, while India has the lowest seroprevalence rate (12.9%-18.1%). Among the old vaccination-naïve population, seropositivity is commonly derived from natural infection.
Conclusions: Decreases in reported JE cases are mainly due to immunization. As JEV is expected to remain in nature and the zoonotic chains, the risk of infection will persist. Hence, it is important to apply JEV vaccination protocols in national immunization programs, prioritizing young children.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961779 | PMC |
| http://dx.doi.org/10.5001/omj.2021.86 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lessons learned from conducting a serological survey for Japanese encephalitis after detecting the first cases in New South Wales, Australia, 2022.
Western Pac Surveill Response J
December 2024
NSW Ministry of Health, St Leonards, New South Wales, Australia.
Problem: The first known locally acquired cases of Japanese encephalitis virus (JEV) infection in New South Wales (NSW), Australia, were identified in March 2022. NSW Health (the state entity for health care in NSW), with its partner agencies, conducted a serological survey to identify the prevalence of JEV antibody responses in high-risk communities in NSW.
Context: JEV infection is rare in Australia; therefore, vaccination is not recommended for the majority of Australians.
Sero-epidemiology and risk factor investigation for exposure to Japanese encephalitis virus in swine populations reared in climatically diverse regions of India.
Trop Anim Health Prod
November 2024
Division of Veterinary Public Health, ICAR - Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.
Japanese encephalitis (JE) is widely prevalent in the Asia-Pacific region. There is limited information on JE virus (JEV) seroprevalence as well as the associated epidemiologic and ecological factors in India. This study aimed to determine the seroprevalence of JEV and associated risk factors in swine populations from climatically diverse regions of the country.
View Article and Find Full Text PDFAustralian vertebrate hosts of Japanese encephalitis virus: a review of the evidence.
Trans R Soc Trop Med Hyg
October 2024
Centre for Planetary Health and Food Security, Griffith University, Gold Coast, QLD 4222, Australia.
Japanese encephalitis virus (JEV) transmission in temperate Australia has underscored a critical need to characterise transmission pathways and identify probable hosts of the virus. This systematic review consolidates existing research on the vertebrate hosts of JEV that are known to exist in Australia. Specifically, we aim to identify probable species involved in JEV transmission, their potential role as hosts and identify critical knowledge gaps.
View Article and Find Full Text PDFThe Role of Wild Boar as Host of Japanese Encephalitis Virus in the Absence of Domestic Pigs.
Viruses
August 2024
Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Article Synopsis
- - Pigs are the main carriers of the Japanese encephalitis virus (JEV), but a 2016 outbreak on Tsushima Island affected residents who did not farm pigs, prompting a study to assess the risk of JEV.
- - A survey of 560 residents in early 2017 revealed high seroprevalence rates of neutralizing antibodies against two JEV strains, with notable levels in older individuals and those who spent time outdoors.
- - Although wild boar samples tested negative for JEV RNA, they showed the presence of neutralizing antibodies, indicating that the virus can still be transmitted on the island and that wild boars may act as amplifying hosts.
Seroprevalences and their associated predictors of chikungunya, dengue, Japanese encephalitis and zika among forest fringe dwellers of Peninsular Malaysia.
Trop Biomed
June 2024
Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Malaysia.
Serological evidence has shown the presence of several mosquito-borne arbovirus infections among the inhabitants of the forest fringe areas of the tropics. Among these infections, Japanese encephalitis, dengue fever, chikungunya fever and Zika fever could be targeted for vaccination to overcome severe infection and limit the disease transmission. Seroprevalence data among this high-risk population are needed to provide an estimate of the potential cost-effectiveness of any vaccine programme targeting these infections.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!